Last reviewed · How we verify

NCT06089161: PRAISE

Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks

Recruiting now NA Last updated 8 May 2025
What this trial tests

NA trial testing Standard of Care in Sleep Apnea in 330 participants. Currently enrolling.

Timeline
19 March 2024
Primary endpoint
31 May 2027
31 May 2028

Quick facts

Lead sponsorUniversity of Miami
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment330
Start date19 March 2024
Primary completion31 May 2027
Estimated completion31 May 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

Adults 60 to 85, any sex, with Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Standard of Care

Trials testing the same drug.

Other recruiting trials for Sleep Apnea

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06089161.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing